ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma
نویسندگان
چکیده
منابع مشابه
An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma.
BACKGROUND Treatment options for patients with nonbulky stage IA-IIA Hodgkin lymphoma include combined modality therapy (CMT) using doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) plus involved-field radiation therapy (IFRT), and chemotherapy with ABVD alone. There are no mature randomized data comparing ABVD with CMT using modern radiation techniques. PATIENTS AND METHODS Using Ge...
متن کاملLimited Stage Follicular Lymphoma: Current Role of Radiation Therapy
Radiation therapy (RT) alone has been considered for a long time as the standard therapeutic option for limited stage FL, due to its high efficacy in terms of local disease control with a quite significant proportion of "cured" patients (without further relapses at 10-15 years). Multiple therapeutic choices are currently accepted for the management of early stage FL at diagnosis, and better sta...
متن کاملThe case for chemotherapy alone for limited-stage Hodgkin's lymphoma.
In “The Case for Combined-Modality Therapy for LimitedStage Hodgkin’s Disease,” [1] authors Hill-Kayser, Plastaras, Tochner, and Glatstein provide a detailed, instructive, and informative discussion of the insights into the management of Hodgkin’s lymphoma that can be derived from the recently published National Cancer Institute of Canada Clinical Trials Group (NCIC CTG)/Eastern Cooperative Onc...
متن کاملEarly Stage W.H.O. Grade I and II Follicular Lymphoma Treated with Radiation Therapy Alone
OBJECTIVES This retrospective study was undertaken to evaluate the outcome of patients with stage I or II (limited stage), grade I-II follicular non-Hodgkin's lymphoma (FL) treated with radiation therapy (RT) alone as initial management. METHODS Patients with stage I or II and pathologically confirmed WHO grade I or II FL treated initially with RT alone between 1982 and 2008 were identified f...
متن کاملAnaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy.
During the last few years, morphological, immunohistochemical, and genetic findings have placed anaplastic large cell lymphoma (ALCL) as a distinct clinicopathologic entity, and several reports have focused on the existence of different subtypes of the tumor. Particular attention has been paid to the ALCL-Hodgkin's-like (HL) subtype, which seems to be on the border between Hodgkin's disease (HD...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: New England Journal of Medicine
سال: 2012
ISSN: 0028-4793,1533-4406
DOI: 10.1056/nejmoa1111961